Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 12Completed 6Not yet recruiting 5Recruiting 4Withdrawn 2Active not recruiting 2Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 438Neoplasms 322Carcinoma, Non-Small-Cell Lung 250Prostatic Neoplasms 240Lung Neoplasms 176Colorectal Neoplasms 158Pancreatic Neoplasms 148Neoplasm Metastasis 142Leukemia, Myeloid, Acute 140Multiple Myeloma 131Lymphoma 128Carcinoma, Hepatocellular 127Ovarian Neoplasms 109Melanoma 109Head and Neck Neoplasms 101Brain Neoplasms 101Recurrence 100Leukemia 97Leukemia, Lymphocytic, Chronic, B-Cell 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Glioblastoma 85Lymphoma, Non-Hodgkin 83Colonic Neoplasms 79Squamous Cell Carcinoma of Head and Neck 76Lymphoma, Follicular 76Carcinoma, Renal Cell 75Lymphoma, Large B-Cell, Diffuse 71Hematologic Neoplasms 69Sarcoma 60Stomach Neoplasms 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Hepatitis B, Chronic × Clear all
NCT02289300 2020-01-13

A Study to Evaluate a Study Drug, DCB-BO1202, for Alleviating Liver Fibrosis in Liver Cancer Patients

A2 Healthcare Taiwan Corporation

Phase 2 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Hepatitis B, Chronic

NCT01831037 2015-01-28

ROLFH

University of Arkansas

Withdrawn
Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis B, Chronic, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡